LMNA and Hutchinson-Gilford progeria syndrome: Thus, we suspected that rapamycin treatment of laminopathic cells could reduce farnesylated prelamin A accumulation and downstream pathogenetic effects, as previously observed for progerin in HGPS cells [16, 31].